Dry Eye Clinical Trial
— CORGIOfficial title:
Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens Type
NCT number | NCT04105842 |
Other study ID # | 41251 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 23, 2019 |
Est. completion date | July 28, 2022 |
Verified date | June 2023 |
Source | University of Waterloo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to refit habitual wearers of daily disposable contact lenses who currently experience symptoms of dry eye and discomfort during lens wear with a different type of daily disposable contact lens. Ocular signs and symptoms of dry eye will be assessed following the guidelines outlined by the Tear Film and Ocular Surface Society (TFOS) in the Dry Eye Workshop II (DEWS II). The performance of the habitual contact lenses and the study lenses will be determined using different optometric assessments. Study lenses will be worn for one month following a daily disposable wear schedule.
Status | Completed |
Enrollment | 40 |
Est. completion date | July 28, 2022 |
Est. primary completion date | July 28, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 17 Years and older |
Eligibility | Inclusion Criteria: 1. Is at least 17 years of age and has full legal capacity to volunteer; 2. Has read and signed an information consent letter; 3. Is willing and able to follow instructions and maintain the appointment schedule; 4. As per TFOS DEWS II, have dry eye symptoms (without CL wear) as determined by an OSDI score of =13 and at least one of the following: 1. Tear osmolarity = 308mOsm/L or interocular difference >8 mOsm/L 2. Non-invasive tear breakup time of < 10 seconds in at least one eye 3. More than 5 spots of corneal staining OR > 9 conjunctival spots in at least one eye 5. Reports dryness while wearing DD CLs with CLDEQ-8 score = 12 and = 203 6. Habitually wears soft spherical DD CLs with a power between +6.00D and -10.00D 7. Manifest spectacle cyl =1.00DC in either eye 8. BCVA =0.20 log MAR each eye with habitual & DT1 9. Acceptable fit with habitual & DT1 10. Willing to wear DT1 CLs at least 3 days per week and 6 hours per day throughout the study Exclusion Criteria: 1. Is participating in any concurrent clinical or research study; 2. Has any known active* ocular disease and/or infection; 3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable; 4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; 5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study; 6. Is pregnant, lactating or planning a pregnancy at the time of enrolment (by self-report); 7. Is aphakic; 8. Has undergone refractive error surgery; 9. Has taken part in another clinical research study within the last 14 days; 10. Current habitual wearer of DT1 11. Any ocular and/or systemic conditions or concomitant medication to contraindicate contact lens wear or be expected to interfere with the primary outcome variables. - For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active. |
Country | Name | City | State |
---|---|---|---|
Canada | Centre for Ocular Research & Education | Waterloo | Ontario |
Lead Sponsor | Collaborator |
---|---|
University of Waterloo | Alcon Research |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | Day 1 after screening with habitual lenses | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | Day 3 after screening with habitual lenses | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | Day 5 after screening with habitual lenses | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | 1-week follow up with habitual lens | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | Day 1 after dispense with delefilcon A | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | Day 3 after dispense with delefilcon A | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | Day 5 after dispense with delefilcon A | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | Day 7 after dispense with delefilcon A | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | Day 21 after dispense with delefilcon A | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | Day 28 after dispense with delefilcon A | |
Primary | Subjective Comfort at End of Day With Contact Lens Wear | Participants rate their end of day comfort on a scale from 0 (worst) to 100 (best). | 1-month follow up with delefilcon A | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | Day 1 after screening with habitual lenses | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | Day 3 after screening with habitual lenses | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | Day 5 after screening with habitual lenses | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | 1-week follow up with habitual lens | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | Day 1 after dispense with delefilcon A | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | Day 3 after dispense with delefilcon A | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | Day 5 after dispense with delefilcon A | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | Day 7 after dispense with delefilcon A | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | Day 21 after dispense with delefilcon A | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | Day 28 after dispense with delefilcon A | |
Primary | Subjective Rating of End of Day Dryness With Contact Lens Wear | Participants rate their end of day dryness on a scale from 0 (worst) to 100 (best). | 1-month follow up with delefilcon A | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | Day 1 after screening with habitual lenses | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | Day 3 after screening with habitual lenses | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | Day 5 after screening with habitual lenses | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | 1-week follow up with habitual lens | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | Day 1 after dispense with delefilcon A | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | Day 3 after dispense with delefilcon A | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | Day 5 after dispense with delefilcon A | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | Day 7 after dispense with delefilcon A | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | Day 21 after dispense with delefilcon A | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | Day 28 after dispense with delefilcon A | |
Primary | Average Lens Wear Time | Average lens wear time is recorded | 1-month follow up with delefilcon A | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | Day 1 after screening with habitual lenses | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | Day 3 after screening with habitual lenses | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | Day 5 after screening with habitual lenses | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | 1-week follow up with habitual lens | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | Day 1 after dispense with delefilcon A | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | Day 3 after dispense with delefilcon A | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | Day 5 after dispense with delefilcon A | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | Day 7 after dispense with delefilcon A | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | Day 21 after dispense with delefilcon A | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | Day 28 after dispense with delefilcon A | |
Primary | Comfortable Lens Wear Time | Comfortable lens wear time (Time of discomfort - Time of insertion) | 1-month follow up with delefilcon A |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102409 -
An Exploratory Clinical Trial to Assess Safety and Tolerability in Subjects With Dry Eye Disease
|
Phase 2 | |
Completed |
NCT05027087 -
The Effect of a Novel Blueberry Supplement on Dry Eye Disease
|
Phase 3 | |
Completed |
NCT06159569 -
Performance and Tolerability of the Medical Device LACRIACT
|
N/A | |
Completed |
NCT04081610 -
Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution
|
Phase 1 | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT05825599 -
PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms
|
N/A | |
Completed |
NCT03418727 -
Dry Eye Disease Study With Brimonidine
|
Phase 2 | |
Active, not recruiting |
NCT04425551 -
Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction
|
N/A | |
Recruiting |
NCT04527887 -
Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED)
|
Phase 4 | |
Not yet recruiting |
NCT06379685 -
Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.
|
Phase 1 | |
Active, not recruiting |
NCT05618730 -
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
|
Phase 1 | |
Completed |
NCT04553432 -
Dry Eye OmniLenz Application of Omnigen Research Study
|
Phase 4 | |
Recruiting |
NCT04109170 -
Dry Eye Evaluation System Based on Bioinformatics
|
||
Completed |
NCT05505292 -
Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers
|
Phase 4 | |
Completed |
NCT04668131 -
Study on Curative Effect and Mechanism of Acupuncture on Neuropathic Pain in Dry Eye Disease
|
N/A | |
Completed |
NCT06176651 -
Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers
|
Phase 4 | |
Not yet recruiting |
NCT02218827 -
Topical Steroid Treatment For Dry Eye
|
N/A | |
Completed |
NCT02235259 -
Efficacy and Safety of XG-104 for the Treatment of Dry Eye
|
Phase 2 | |
Completed |
NCT01959854 -
Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye
|
N/A | |
Completed |
NCT01629706 -
Determination of Cell Population in Solution-Induced Corneal Staining (SICS) and Symptomatic Versus Asymptomatic Lens Wearers
|
N/A |